TNFRSF10A and cancer: TRAIL can bind to TRAIL receptors (DcR1(TRAIL-R3), DcR2(TRAIL-R4), OPG, DR4 (TRAIL-R1) and DR5 (TRAIL-R2)), and induce apoptosis of target cancer cells [98].